CJ
FLGT icon

Caitlin John’s Fulgent Genetics FLGT Stock Holding History

Caitlin John’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16
Closed -$254 – 1022
2026
Q1 		$254 Hold
16
– – ﹤0.01% 889
2025
Q4 		$420 Hold
16
– – ﹤0.01% 865
2025
Q3 		$362 Buy
+16
New +$330 ﹤0.01% 835
2025
Q1 		– Sell
-16
Closed -$296 – 344
2024
Q4 		$296 Hold
16
– – ﹤0.01% 806
2024
Q3 		$295 Hold
16
– – ﹤0.01% 799
2024
Q2 		$314 Hold
16
– – ﹤0.01% 794
2024
Q1 		$347 Hold
16
– – ﹤0.01% 821
2023
Q4 		$463 Buy
+16
New +$428 ﹤0.01% 812

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Caitlin John's FLGT Position: Q2 2026 in Review

Caitlin John sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 16 shares — an estimated $254 sold.

Caitlin John first reported a position in FLGT in Q4 2023 and held it in 8 quarters. The position peaked at $463 in Q4 2023. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Caitlin John reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Caitlin John sold 16 Fulgent Genetics shares in Q2 2026, an estimated $254.
  • Caitlin John first reported a position in Fulgent Genetics in Q4 2023 and held it in 8 quarters.
  • Caitlin John's Fulgent Genetics position peaked at $463 in Q4 2023.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.